TGF-β1 mediates epithelial to mesenchymal transition via the TGF-β/Smad pathway in squamous cell carcinoma of the head and neck

Oncology Reports

Volumn 25, Issue 6, 2011, Pages 1581-1587

  Yu, Changyun ^a   Liu, Yong ^a   Huang, Donghai ^a   Dai, Yaozhang ^a   Cai, Gengming ^a   Sun, Jinjie ^a   Xu, Ting ^a   Tian, Yongquan ^a   Zhang, Xin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Epithelial to mesenchymal transition; Metastasis; Smad2; Squamous cell carcinoma of the head and neck; Transforming growth factor 1

Indexed keywords

SMAD PROTEIN; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL CONTACT; CELL DIFFERENTIATION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FIBROBLAST; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MESENCHYME CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; UPREGULATION; WOUND HEALING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; HEAD AND NECK NEOPLASMS; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79954484889     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1251     Document Type: Article

References (42)

1. Hunter KD, Parkinson EK and Harrison PR: Profiling early head and neck cancer. Nat Rev Cancer 5: 127-135, 2005. (Pubitemid 40220338)
2. Cancer Facts and Figures, 2005. American Cancer Society, Atlanta, p17, 2005.
3. Thompson EW, Newgreen DF and Tarin D: Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65: 5991-5995, 2005.
4. Geho DH, Bandle RW, Clair T and Liotta LA: Physiological mechanisms of tumor-cell invasion and migration. Physiology 20: 194-200, 2005. (Pubitemid 40807057)
5. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005. (Pubitemid 41267170)
6. Thiery JP: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746, 2003.
7. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
8. Grünert S, Jechlinger M and Beug H: Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 4: 657-665, 2003. (Pubitemid 36934968)
9. Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, Rayala S, Ohshiro K, Rosenthal DI, Weber RS, Gallick GE and El-Naggar AK: Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 112: 2088-2100, 2008. (Pubitemid 351574086)
10. Akhurst RJ and Derynck R: TGF-beta signaling in cancer - a double-edged sword. Trends Cell Biol 11: S44-S51, 2001.
11. Zavadil J and Bottinger E: TGF-β and epithelial-mesenchymal transitions. Oncogene 24: 5764-5774, 2005.
12. Valcourt U, Kowanetz M, Niimi H, Heldin CH and Moustakas A: TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 16: 1987-2002, 2005.
13. Kim JH, Jang YS, Eom KS, Hwang YI, Kang HR, Jang SH, Kim CH, Park YB, Lee MG, Hyun IG, Jung KS and Kim DG: Transforming growth factor beta1 induces epithelial-to-mesenchymal transition of A549 cells. J Korean Med Sci 22: 898-904, 2007.
14. Rees JR, Onwuegbusi BA, Save VE, Alderson D and Fitzgerald RC: In vivo and in vitro evidence for transforming growth factor-β-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Res 66: 9583-9590, 2006.
15. Sacks PG: Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev 15: 27-51, 1996.
16. Zhau HE, Odero-Marah V, Lue HW, Nomura T, Wang R, Chu G, Liu ZR, Zhou BP, Huang WC and Chung LW: Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model. Clin Exp Metastasis 25: 601-610, 2008.
17. Liu Y, Xie C, Zhang X, Huang D, Zhou X, Tan P, Qi L, Hu G, Tian Y and Qiu Y: Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance. Eur J Cancer 46: 3007-3015, 2010.
18. Zhang X, Liu Y, Gilcrease MZ, Yuan XH, Clayman GL, Adler-Storthz K and Chen Z: A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 95: 1663-1672, 2002.
19. Derynck R and Zhang YE: Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425: 577-584, 2003. (Pubitemid 37280136)
20. Yilmaz M and Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28: 15-33, 2009.
21. Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973-981, 2006.
22. Cavallaro U and Christofori G: Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 4: 118-132, 2004. (Pubitemid 38198740)
23. De Herreros AG, Peiró S, Nassour M and Savagner P: Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia 15: 135-147, 2010.
24. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD and Chodosh LA: The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8: 197-209, 2005. (Pubitemid 41317591)
25. Brabletz T, Herrmann K, Jung A, Faller G and Kirchner T: Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol 156: 865-870, 2000. (Pubitemid 30626945)
26. Giannelli G, Bergamini C, Fransvea E, Sgarra C and Antonaci S: Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 129: 1375-1383, 2005. (Pubitemid 41597379)
27. Javle MM, Gibbs JF, Iwata KK, Pak Y, Rutledge P, Yu J, Black JD, Tan D and Khoury T: Epithelial to mesenchymal transition (EMT) and activites extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer. Ann Surg Oncol 14: 3527-3533, 2007. (Pubitemid 350160113)
28. Blick T, Widodo E, Hugo H, Waltham M, Lenburg ME, Neve RM and Thompson EW: Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin Exp Metastasis 25: 629-642, 2008.
29. Vergara D, Merlot B, Lucot JP, Collinet P, Vinatier D, Fournier I and Salzet M: Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett 291: 59-66, 2010.
30. De Larco JE and Todaro GJ: Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 75: 4001-4005, 1978. (Pubitemid 8399860)
31. Bierie B and Moses HL: TGF-β and cancer. Cytokine Growth Factor Rev 17: 29-40, 2006.
32. Blobe GC, Schiemann WP and Lodish HF: Role of transforming growth factor in human disease. N Engl J Med 342: 1350-1358, 2000. (Pubitemid 30408720)
33. Akhurst RJ and Balmain A: Genetic events and the role of TGFβ in epithelial tumour progression. J Pathol 187: 82-90, 1999. (Pubitemid 29009837)
34. Batlle E, Sancho E, Franci C, Domínguez D, Monfar M, Baulida J and García DHA: The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumor cells. Nat Cell Biol 2: 84-89, 2000.
35. Moreno G, Cubillo E, Sarrió D, Peinado H, Rodríguez-Pinilla SM, Villa S, Bolós V, Jordá M, Fabra A, Portillo F, Palacios J and Cano A: Genetic profiling of epithelial cells expressing E-Cadherin repressor a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 66: 9543-9556, 2006.
36. Zhen X, Shen MX, Ma DZ, Wang LY and Zha XL: TGF-β-promoted epithelial-to-mesenchymal transformation and cell adhesion contribute to TGF-β-enhanced cell migration in SMMC-7721 cells. Cell Res 13: 343-350, 2003.
37. Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E and Koteish A: Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282: 22089-22101, 2007. (Pubitemid 47195788)
38. Li Y, Zhang J, Fang L, Luo P, Peng J and Du X: Lefty A attenuates the TGF-beta-induced epithelial to mesenchymal transition of human renal proximal epithelial tubular cells. Mol Cell Biochem 339: 263-270, 2010.
39. Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM, Lenburg M and Thiagalingam S: Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res 70: 968-978, 2010.
40. Oft M, Akhurst RJ and Balmain A: Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol 4: 487-494, 2002. (Pubitemid 34752433)
41. Piek E, Moustakas A, Kurisaki A, Heldin CH and ten Dijke P: TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 112: 4557-4568, 1999. (Pubitemid 30034805)
42. Tian F, Byfield SD, Parks WT, Stuelten CH, Nemani D, Zhang YE and Roberts AB: Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res 64: 4523-4530, 2004. (Pubitemid 38856924)